Australia · Delayed Price · Currency is AUD IPH Limited Earnings Call Transcripts
Fiscal Year 2026
-
Group underlying EBITDA rose 6.6% and net profit increased 10.5% year-over-year, driven by strong Canadian and Asian performance, while ANZ faced headwinds from declining U.S. filings. Cash flow and dividends improved, with ongoing focus on AI-driven efficiencies and capital management.
Fiscal Year 2025
-
The AGM covered financial growth, board renewal, and CEO succession, with a 4% dividend increase and strategic focus on new markets and operational efficiencies. Shareholders discussed U.S. market declines and CIPO disruptions, while all resolutions were put to a poll.
-
Revenue grew 16.5% to AUD 710.3 million, driven by Canadian acquisitions and organic ANZ growth. Underlying EBITDA rose 6%, with strong cash flow and a 4% dividend increase. Cost synergies and operational efficiencies are set to deliver AUD 8–10 million in annual savings from FY 2026.
-
Solid half-year results with 11% EBITDA and 20% net profit growth, driven by organic gains in ANZ and recovery in Asia. Canadian operations rebounding from SIPO disruptions, with Bereskin & Parr integration ahead of plan and cost synergies exceeding expectations.
Fiscal Year 2024
-
The meeting highlighted strong revenue and earnings growth, driven by Canadian acquisitions and organic improvements in Australia and New Zealand. Strategic focus shifted to integration, operational efficiency, and organic growth, with updated executive remuneration and ongoing board renewal. Key risks included workflow disruptions in Canada and market softness in Asia.
-
Delivered strong FY 2024 results with double-digit EBITDA and net profit growth, driven by Canadian acquisitions and a turnaround in ANZ. Announced Bereskin & Parr acquisition and capital raise, with integration synergies and margin improvements expected in Canada.